Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05437965

National Multicenter Cohort Registry Study of Rapid rEcurrences of Coronary Unexplained In-stent Restenosis

This project aims to establish a clinical cohort and diagnostic assessment framework by conducting a national multicenter cohort registry study. Through the collection of patients' clinical characteristics, it will achieve the registration, management, follow-up, and analysis of patients with Rapid rEcurrences of Coronary Unexplained in-stent Restenosis (RECUR).

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥ 18 years;
  • Patients meeting the diagnostic criteria for Rapid rEcurrences of Coronary Unexplained in-stent Restenosis (RECUR);
  • Patients fully informed about the trial procedures who provide written informed consent.

Exclusion criteria

  • Patients presenting with any of the following:
  • Other severe comorbidities (e.g., malignant tumors, heart failure) with a life expectancy <12 months;
  • Known autoimmune/rheumatic diseases including systemic lupus erythematosus, Takayasu arteritis, Behçet's disease, polyarteritis nodosa, Wegener granulomatosis (granulomatosis with polyangiitis), eosinophilic arteritis, giant cell arteritis, rheumatoid arthritis, or IgG4-related disease;
  • Variant angina (Prinzmetal's angina);
  • Coronary artery dissection;
  • Thrombophilia;
  • Stent underexpansion.
  • Presence of psychiatric disorders;
  • Known inability to complete expected study follow-up for any reason;
  • Patients deemed ineligible for enrollment by the investigator.

Treatment and study plan

Treatment made by experienced clinicians

Other

Treatment made by experienced clinicians

Primary outcomes

  1. Target vessel failure

    Time frame: 10 year

    Time to the incidence of target vessel failure, a composite of cardiovascular death, target vessel-related myocardial infarction, and target vessel-related revascularization.

Study contacts

Contact information is provided by the study sponsor or research team.

Hong Jian Wang, Dr.

CONTACT

[email protected]

008613910008985

Sponsors and collaborators

Lead sponsor

China National Center for Cardiovascular Diseases

Other Gov

Collaborators

  • Chinese Academy of Medical Sciences, Fuwai Hospital
  • First Affiliated Hospital Xi'an Jiaotong University
  • Peking Union Medical College Hospital
  • The First Hospital of Jilin University

Registry information

Acronym: RECUR Registry

Important dates

Study start
2020
Primary completion
2035
Study completion
2035
First posted
Jun 29, 2022
Registry last updated
Aug 8, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.